260 related articles for article (PubMed ID: 17516857)
1. Review of the factors affecting bioavailability of soy isoflavones in humans.
Nielsen IL; Williamson G
Nutr Cancer; 2007; 57(1):1-10. PubMed ID: 17516857
[TBL] [Abstract][Full Text] [Related]
2. Increased probiotic yogurt or resistant starch intake does not affect isoflavone bioavailability in subjects consuming a high soy diet.
Larkin TA; Price WE; Astheimer LB
Nutrition; 2007 Oct; 23(10):709-18. PubMed ID: 17656069
[TBL] [Abstract][Full Text] [Related]
3. One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women.
Védrine N; Mathey J; Morand C; Brandolini M; Davicco MJ; Guy L; Rémésy C; Coxam V; Manach C
Eur J Clin Nutr; 2006 Sep; 60(9):1039-45. PubMed ID: 16482068
[TBL] [Abstract][Full Text] [Related]
4. Effect of glycosidation of isoflavones on their bioavailability and pharmacokinetics in aged male rats.
Sepehr E; Cooke GM; Robertson P; Gilani GS
Mol Nutr Food Res; 2009 May; 53 Suppl 1():S16-26. PubMed ID: 19437481
[TBL] [Abstract][Full Text] [Related]
5. Higher bioavailability of isoflavones after a single ingestion of a soya-based supplement than a soya-based food in young healthy males.
Vergne S; Bennetau-Pelissero C; Lamothe V; Chantre P; Potier M; Asselineau J; Perez P; Durand M; Moore N; Sauvant P
Br J Nutr; 2008 Feb; 99(2):333-44. PubMed ID: 17678570
[TBL] [Abstract][Full Text] [Related]
6. Soy processing affects metabolism and disposition of dietary isoflavones in ovariectomized BALB/c mice.
Allred CD; Twaddle NC; Allred KF; Goeppinger TS; Churchwell MI; Ju YH; Helferich WG; Doerge DR
J Agric Food Chem; 2005 Nov; 53(22):8542-50. PubMed ID: 16248551
[TBL] [Abstract][Full Text] [Related]
7. Low activities of intestinal lactase suppress the early phase absorption of soy isoflavones in Japanese adults.
Tamura A; Shiomi T; Hachiya S; Shigematsu N; Hara H
Clin Nutr; 2008 Apr; 27(2):248-53. PubMed ID: 18237824
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability and urinary excretion of isoflavones in humans: effects of soy-based supplements formulation and equol production.
Vergne S; Titier K; Bernard V; Asselineau J; Durand M; Lamothe V; Potier M; Perez P; Demotes-Mainard J; Chantre P; Moore N; Bennetau-Pelissero C; Sauvant P
J Pharm Biomed Anal; 2007 Mar; 43(4):1488-94. PubMed ID: 17110073
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women.
Zubik L; Meydani M
Am J Clin Nutr; 2003 Jun; 77(6):1459-65. PubMed ID: 12791624
[TBL] [Abstract][Full Text] [Related]
10. Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora.
Rowland IR; Wiseman H; Sanders TA; Adlercreutz H; Bowey EA
Nutr Cancer; 2000; 36(1):27-32. PubMed ID: 10798213
[TBL] [Abstract][Full Text] [Related]
11. Altered kinetics and extent of urinary daidzein and genistein excretion in women during chronic soya exposure.
Lu LJ; Lin SN; Grady JJ; Nagamani M; Anderson KE
Nutr Cancer; 1996; 26(3):289-302. PubMed ID: 8910911
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of isoflavones, daidzein and genistein, after ingestion of soy beverage compared with soy extract capsules in postmenopausal Thai women.
Anupongsanugool E; Teekachunhatean S; Rojanasthien N; Pongsatha S; Sangdee C
BMC Clin Pharmacol; 2005 Mar; 5():2. PubMed ID: 15743537
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of soy isoflavones in rats Part I: application of accurate methodology for studying the effects of gender and source of isoflavones.
Sepehr E; Cooke G; Robertson P; Gilani GS
Mol Nutr Food Res; 2007 Jul; 51(7):799-812. PubMed ID: 17576640
[TBL] [Abstract][Full Text] [Related]
14. Higher bioavailability of isoflavones after a single ingestion of aglycone-rich fermented soybeans compared with glucoside-rich non-fermented soybeans in Japanese postmenopausal women.
Okabe Y; Shimazu T; Tanimoto H
J Sci Food Agric; 2011 Mar; 91(4):658-63. PubMed ID: 21104834
[TBL] [Abstract][Full Text] [Related]
15. Absorption of isoflavones in humans: effects of food matrix and processing.
de Pascual-Teresa S; Hallund J; Talbot D; Schroot J; Williams CM; Bugel S; Cassidy A
J Nutr Biochem; 2006 Apr; 17(4):257-64. PubMed ID: 16109484
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia.
Fischer L; Mahoney C; Jeffcoat AR; Koch MA; Thomas BE; Valentine JL; Stinchcombe T; Boan J; Crowell JA; Zeisel SH
Nutr Cancer; 2004; 48(2):160-70. PubMed ID: 15231450
[TBL] [Abstract][Full Text] [Related]
17. Sex and long-term soy diets affect the metabolism and excretion of soy isoflavones in humans.
Lu LJ; Anderson KE
Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1500S-1504S. PubMed ID: 9848524
[TBL] [Abstract][Full Text] [Related]
18. Rapid gut transit time and slow fecal isoflavone disappearance phenotype are associated with greater genistein bioavailability in women.
Zheng Y; Hu J; Murphy PA; Alekel DL; Franke WD; Hendrich S
J Nutr; 2003 Oct; 133(10):3110-6. PubMed ID: 14519793
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements.
Setchell KD; Brown NM; Desai P; Zimmer-Nechemias L; Wolfe BE; Brashear WT; Kirschner AS; Cassidy A; Heubi JE
J Nutr; 2001 Apr; 131(4 Suppl):1362S-75S. PubMed ID: 11285356
[TBL] [Abstract][Full Text] [Related]
20. Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women.
Setchell KD; Faughnan MS; Avades T; Zimmer-Nechemias L; Brown NM; Wolfe BE; Brashear WT; Desai P; Oldfield MF; Botting NP; Cassidy A
Am J Clin Nutr; 2003 Feb; 77(2):411-9. PubMed ID: 12540402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
